Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Sets Highest Risk Level For Over 6,000 Bags
Lay’s recall increased to highest level, could cause ‘death’: FDA
The oversight could result in “death,” at least for those with a milk allergy or sensitivity, says the FDA. FDA initiated the recall on Dec. 13 and announced three days later that it was recalling the chips due to a potential or undeclared allergen. At present, no allergic reactions have been reported.
Lay’s potato chip recall now elevated to FDA’s highest-risk level
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause adverse health consequences. In December, Texas-based food manufacturer Frito Lay recalled a limited number of Lay’s Classic 13oz because the product could contain undeclared milk ingredients.
Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States
A recall which was issued across nine states has now been given the highest risk classification by the federal agency.
Axsome Therapeutics, FDA and migraine
US FDA approves Axsome Therapeutics' migraine drug
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
Axsome Therapeutics announces FDA approval of Symbravo
Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in
Axsome gets FDA approval for Symbravo for migraine
Axsome Therapeutics (NASDAQ:AXSM) has received FDA approval for its drug Symbravo for the acute treatment of migraine with or without aura in adults. Symbravo, a combination of meloxicam and rizatriptan,
Novo Nordisk’s Ozempic Gets FDA Approval
FDA Approves Ozempic to Treat Kidney Disease
The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease.
US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,
2h
on MSN
US FDA identifies cybersecurity risks in certain patient monitors
The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with ...
The American Spectator
18h
Trump: Look at the Slow-Moving FDA
The U.S. Food and Drug Administration’s recent approval of a product known as Zyn is a leap forward for the cause of tobacco ...
Soap Central Lifestyle on MSN
12h
Why did FDA set Walmart's Broccoli Recall to Class I? Deadly reason explored
The Food and Drug Administration has updated the recall of Broccoli florets sold at Walmart to class I risk level, which is the highest level of risk.
4d
on MSN
Food and Drug Administration wants to put nutrition labels front and center on food products
The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...
Opinion
7h
on MSN
Opinion
The FDA’s new, same-old food labels demand better obesity solutions
All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.
Opinion
1h
Opinion
Do food warning labels actually work? Answering your questions.
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
1h
The Return of Snake Oil
The Trump administration is poised to supercharge America’s appetite for supplements.
4h
5 takeaways from RFK Jr.’s first confirmation hearing as Trump’s nominee for health secretary
Robert F. Kennedy Jr. was pressed to clarify his views on vaccines, abortion, and public health priorities in his first ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
United States
Ozempic
Novo Nordisk
Feedback